GlassScriptPhysician profile
Anthony Saracino
NPI 1245295997
$2,948.91
in general payments reported to CMS, 2019-2025
19 companies · $828 in 2025
The $828 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $32.19 · 2021: $234 · 2022: $1,491 · 2023: $16.90 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,349.46 | 2021-2022 | |
| Janssen Biotech, INC. | $258.90 | 2019-2025 | Rybrevant, Carvykti, Tecvayli |
| Astellas Pharma US INC | $212.14 | 2019-2023 | Myrbetriq |
| Dendreon Pharmaceuticals LLC | $200.91 | 2025 | Provenge |
| Abbvie INC. | $125.00 | 2025 | |
| Amgen INC. | $125.00 | 2025 | Repatha |
| Teleflex LLC | $110.42 | 2021 | |
| Janssen Pharmaceuticals, INC | $108.27 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $95.25 | 2025 | Airsupra |
| Karl Storz Endoscopy-America | $84.88 | 2020-2021 | |
| Baxter Healthcare | $67.43 | 2022 | |
| Boston Scientific Corporation | $63.45 | 2019-2025 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $45.34 | 2025 | |
| Incyte Corporation | $26.24 | 2025 | Monjuvi, Zynyz |
| Glaxosmithkline, LLC. | $19.04 | 2025 | Jemperli, Zejula |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $17.28 | 2019 | |
| Endo Pharmaceuticals INC. | $17.00 | 2021 | |
| C. R. Bard, INC. & Subsidiaries | $11.77 | 2019 | |
| Antares Pharma, INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Saracino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.